glp-1 coverage insurance news today Does health cover drugs? Tips that may help you save on these blockbuster medications GLP-1 Coverage in Employer Plans

Cellular senescence or stemness: hypoxia flips the coin

NeuroRX (2005) 2(1):314

Stelara (ustekinumab) Disease area(s): Immunology Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $10.36 billion Why it sold so well: J&Js immunology blockbuster Stelara generated approximately $10.36 billion in global sales in 2024, a 4.6% decline from the previous year

claims data from more than 1 million female patients ages 12 to 45 with a newly observed and confirmed diagnosis of PMOS (E28.2) between 2020 and 2025

Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) are available upon request to support compliance with European research standards